Veracyte Inc logo

VCYT - Veracyte Inc News Story

$46.91 -8.5  -15.3%

Last Trade - 04/03/21

Sector
Healthcare
Size
Mid Cap
Market Cap £2.26bn
Enterprise Value £2.01bn
Revenue £84.6m
Position in Universe 1752nd / 6647

BRIEF-Caredx And Veracyte Announce Partnership For Transplant Rejection Testing On Ncounter System

Thu 14th May, 2020 1:59pm
May 14 (Reuters) - CareDx Inc  CDNA.O :
    * CAREDX AND VERACYTE ANNOUNCE EXCLUSIVE PARTNERSHIP FOR
TRANSPLANT REJECTION TESTING ON NCOUNTER SYSTEM
    * CAREDX INC - CO WILL BECOME EXCLUSIVE WORLDWIDE
COMMERCIALIZATION PARTNER FOR SOLID ORGAN TRANSPLANT-REJECTION
TESTS ON VERACYTE'S DIAGNOSTIC PLATFORM

Source text for Eikon:  ID:nBw7BSrSpa 
Further company coverage:  CDNA.O 

 ((Reuters Messaging: Reuters.Briefs@thomsonreuters.com))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.